Atlas Trials

A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal Cancer

Clinical trial NCT07573397 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07573397
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Esophageal Cancer
Start date
2026-05-06
Primary completion
2028-05-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.